Frontiers in immunology · 2021
Case Report: Signal Transducer and Activator of Transcription 3 Gain-of-Function and Spectrin Deficiency: A Life-Threatening Case of Severe Hemolytic Anemia.
Клинический случайПоддержка исследования: вне правительства СШАСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ciullini Mannurita Sara, Goda Rayan, Schiavo Ebe, Coniglio Maria Luisa, Azzali Annachiara, Fotzi Ilaria, Tondo Annalisa, Tintori Veronica, Frenos Stefano, Sanvito Maria Chiara, Vignoli Marina, Luceri Cristina, Bigagli Elisabetta, Grassi Alessia, D'Elios Mario Milco, Favre Claudio, Gambineri Eleonora
Аннотация
STAT3 gain-of-function (GOF) mutations can be responsible for an incomplete phenotype mainly characterized by hematological autoimmunity, even in the absence of other organ autoimmunity, growth impairment, or severe infections. We hereby report a case with an incomplete form of STAT3 GOF intensified by a concomitant hereditary hematological disease, which misleads the diagnosis. The patient presented with lymphadenopathy, splenomegaly, hypogammaglobulinemia, and severe autoimmune hemolytic anemia (AIHA) with critical complications, including stroke. A Primary Immune Regulatory Disorders (PIRD) was suspected, and molecular analysis revealed a de novo STAT3 gain-of-function mutation. The response to multiple immune suppressive treatments was ineffective, and further investigations revealed a spectrin deficiency. Ultimately, hematopoietic stem cell transplantation from a matched unrelated donor was able to cure the patient. Our case shows an atypical presentation of STAT3 GOF associated with hereditary spherocytosis, and how achievement of a good long-term outcome depends on a strict clinical and laboratory monitoring, as well as on prompt therapeutic intervention.
Предметные рубрики MeSH
AgammaglobulinemiaAge of OnsetAnemia, Hemolytic, AutoimmuneChildCyclosporineCytochrome P-450 CYP3AFemaleGain of Function MutationGerm-Line MutationGraft vs Host DiseaseGrowth DisordersHematopoietic Stem Cell TransplantationHumansImmunoglobulins, IntravenousImmunosuppressive AgentsLymphoproliferative DisordersMutation, MissensePolymorphism, Single NucleotidePrednisoloneRetinal HemorrhageSTAT3 Transcription FactorSpectrinUnrelated Donors